HSBC Holdings’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,700
Closed -$293K 3290
2020
Q4
$293K Buy
+3,700
New +$217K ﹤0.01% 2582
2020
Q1
Sell
-5,796
Closed -$411K 3145
2019
Q4
$411K Buy
+5,796
New +$420K ﹤0.01% 2344
2018
Q4
Sell
-2,573
Closed -$237K 2775
2018
Q3
$237K Buy
+2,573
New +$245K ﹤0.01% 2342
2018
Q2
Sell
-2,952
Closed -$328K 2751
2018
Q1
$328K Buy
2,952
+500
+20% +$56K ﹤0.01% 2145
2017
Q4
$252K Buy
+2,452
New +$244K ﹤0.01% 1801
2017
Q1
Sell
-7,953
Closed -$626K 2716
2016
Q4
$626K Buy
+7,953
New +$618K ﹤0.01% 1666

Other funds holding CMD

HSBC Holdings's CMD Position: Q1 2021 in Review

HSBC Holdings sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 3,700 shares — an estimated $293K sold.

HSBC Holdings first reported a position in CMD in Q4 2016 and held it in 6 quarters. The position peaked at $626K in Q4 2016. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • HSBC Holdings reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • HSBC Holdings sold 3,700 Cantel Medical Corporation shares in Q1 2021, an estimated $293K.
  • HSBC Holdings first reported a position in Cantel Medical Corporation in Q4 2016 and held it in 6 quarters.
  • HSBC Holdings's Cantel Medical Corporation position peaked at $626K in Q4 2016.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on HSBC Holdings's 13F filing for Q1 2021, filed 14 May 2021.